Retatrutide is an investigational triple receptor agonist that targets three hormonal pathways simultaneously: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Evidence-Based Alternatives 1
The prescribed concentration, injection volume and escalation schedule depend on the clinician and dispensing pharmacy
Sosne, G., Qiu, P., Christopherson, P
I would be surprised if that could be achieved. Sarah Gibson, the founder and CEO of Vitality Health Matrix, which is focused on womens metabolic health, says her medical practice tried offering compounded GLP-1 pills to patients for about six months
Each pharmacy may have different ways of making it